Movatterモバイル変換

[0]ホーム
URL:

GB0701367D0 - Novel pharmaceutical compositions - Google Patents

Novel pharmaceutical compositions

Info

Publication number
GB0701367D0
GB0701367D0GB0701367AGB0701367AGB0701367D0GB 0701367 D0GB0701367 D0GB 0701367D0GB 0701367 AGB0701367 AGB 0701367AGB 0701367 AGB0701367 AGB 0701367AGB 0701367 D0GB0701367 D0GB 0701367D0
Authority
GB
United Kingdom
Prior art keywords
pharmaceutical compositions
novel pharmaceutical
novel
compositions
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0701367A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group LtdfiledCriticalGlaxo Group Ltd
Priority to GB0701367ApriorityCriticalpatent/GB0701367D0/en
Publication of GB0701367D0publicationCriticalpatent/GB0701367D0/en
Priority to MX2009007916Aprioritypatent/MX2009007916A/en
Priority to AU2008208920Aprioritypatent/AU2008208920A1/en
Priority to CA002676357Aprioritypatent/CA2676357A1/en
Priority to EP08708029Aprioritypatent/EP2129381A1/en
Priority to PCT/EP2008/050625prioritypatent/WO2008090117A1/en
Priority to KR1020097017503Aprioritypatent/KR20090112722A/en
Priority to JP2009546728Aprioritypatent/JP2010516731A/en
Priority to US12/524,415prioritypatent/US20100105688A1/en
Priority to BRPI0807972-2A2Aprioritypatent/BRPI0807972A2/en
Priority to PCT/EP2008/050621prioritypatent/WO2008090114A1/en
Priority to US12/524,434prioritypatent/US8093268B2/en
Priority to CN200880009655Aprioritypatent/CN101641099A/en
Priority to JP2009546731Aprioritypatent/JP2010516734A/en
Priority to EP08708025Aprioritypatent/EP2117538A1/en
Priority to EA200970706Aprioritypatent/EA200970706A1/en
Ceasedlegal-statusCriticalCurrent

Links

GB0701367A2007-01-242007-01-24Novel pharmaceutical compositionsCeasedGB0701367D0 (en)

Priority Applications (16)

Application NumberPriority DateFiling DateTitle
GB0701367AGB0701367D0 (en)2007-01-242007-01-24Novel pharmaceutical compositions
EA200970706AEA200970706A1 (en)2007-01-242008-01-21 NEW PHARMACEUTICAL COMPOSITIONS
KR1020097017503AKR20090112722A (en)2007-01-242008-01-21 3,5-diamino-6- (2,3-dichlorophenyl) -1,2,4-triazine or R (-)-2,4-diamino-5- (2,3-dichlorophenyl)- Pharmaceutical composition comprising 6-fluoromethyl pyrimidine and NX1
US12/524,415US20100105688A1 (en)2007-01-242008-01-21Pharmaceutical compositions comprising 3,5-diamino-6-(2,3-dichlophenyl)-1,2,4-triazine or r(-)-2,4-diamino-5-(2,3-dichlorophenyl)-6-fluoromethyl pyrimidine and an nk1
CA002676357ACA2676357A1 (en)2007-01-242008-01-21Pharmaceutical compositions comprising 3, 5-diamin0-6- (2, 3-dichl0phenyl) -l, 2, 4-triazine or r (-) -2, 4-diamino-5- (2, 3-dichlorophenyl) -6-fluoromethyl pyrimidine and an nk1
EP08708029AEP2129381A1 (en)2007-01-242008-01-21Pharmaceutical compositions comprising 3, 5-diamin0-6- (2, 3-dichl0phenyl) -l, 2, 4-triazine or r (-) -2, 4-diamino-5- (2, 3-dichlorophenyl) -6-fluoromethyl pyrimidine and an nk1
PCT/EP2008/050625WO2008090117A1 (en)2007-01-242008-01-21Pharmaceutical compositions comprising 3, 5-diamin0-6- (2, 3-dichl0phenyl) -l, 2, 4-triazine or r (-) -2, 4-diamino-5- (2, 3-dichlorophenyl) -6-fluoromethyl pyrimidine and an nk1
MX2009007916AMX2009007916A (en)2007-01-242008-01-21Pharmaceutical compositions comprising 3, 5-diamin0-6- (2, 3-dichl0phenyl) -l, 2, 4-triazine or r (-) -2, 4-diamino-5- (2, 3-dichlorophenyl) -6-fluoromethyl pyrimidine and an nk1.
JP2009546728AJP2010516731A (en)2007-01-242008-01-21 Pharmaceutical composition comprising 2-methoxy-5- (5-trifluoromethyl-tetrazol-1-yl) -benzyl]-(2S-phenyl-piperidin-3S-yl) -amine
AU2008208920AAU2008208920A1 (en)2007-01-242008-01-21Pharmaceutical compositions comprising 3, 5-diamin0-6- (2, 3-dichl0phenyl) -l, 2, 4-triazine or R(-) -2, 4-diamino-5- (2, 3-dichlorophenyl) -6-fluoromethyl pyrimidine and an NK1
BRPI0807972-2A2ABRPI0807972A2 (en)2007-01-242008-01-21 PHARMACEUTICAL COMPOSITIONS UNDERSTANDING 3,5-DIAMINO-6- (2,3-DICHLOPHENYL) -L, 2,4-TRIAZINE OR R (-) - 2,4-DIAMINO-5- (2,3-DICHLOROPHENYL) -6- FLUOROMETILPIRIM IDINA AND ONE NK1
PCT/EP2008/050621WO2008090114A1 (en)2007-01-242008-01-21Pharmaceutical compositions comprising 2-methoxy-5- (5-trifluoromethyl-tetrazol-i-yl-benzyl) - (2s-phenyl-piperidin-3s-yl-)
US12/524,434US8093268B2 (en)2007-01-242008-01-21Pharmaceutical compositions comprising 2-methoxy-5-(5-trifluoromethyl-tetrazol-1-yl-benzyl)-(2S-phenylpiperidin-3S-yl-)
CN200880009655ACN101641099A (en)2007-01-242008-01-21Pharmaceutical compositions comprising 3, 5-diamin0-6- (2, 3-dichl0phenyl) -l, 2, 4-triazine or r (-) -2, 4-diamino-5- (2, 3-dichlorophenyl) -6-fluoromethyl pyrimidine and an nk1
JP2009546731AJP2010516734A (en)2007-01-242008-01-21 3,5-diamino-6- (2,3-dichlorophenyl) -1,2,4-triazine or R (-)-2,4-diamino-5- (2,3-dichlorophenyl) -6-fluoromethylpyrimidine A pharmaceutical composition comprising
EP08708025AEP2117538A1 (en)2007-01-242008-01-21Pharmaceutical compositions comprising 2-methoxy-5- (5-trifluoromethyl-tetrazol-i-yl-benzyl) - (2s-phenyl-piperidin-3s-yl-)

Applications Claiming Priority (1)

Application NumberPriority DateFiling DateTitle
GB0701367AGB0701367D0 (en)2007-01-242007-01-24Novel pharmaceutical compositions

Publications (1)

Publication NumberPublication Date
GB0701367D0true GB0701367D0 (en)2007-03-07

Family

ID=37872718

Family Applications (1)

Application NumberTitlePriority DateFiling Date
GB0701367ACeasedGB0701367D0 (en)2007-01-242007-01-24Novel pharmaceutical compositions

Country Status (1)

CountryLink
GB (1)GB0701367D0 (en)

Similar Documents

PublicationPublication DateTitle
HUS1800007I1 (en)Pharmaceutical composition
IL247741A0 (en)Pharmaceutical compositions
IL201891A0 (en)Novel pharmaceutical composition
EP2133095A4 (en)Pharmaceutical composition
EP2133094A4 (en)Pharmaceutical composition
EP2222313A4 (en)Pharmaceutical compositions
PL2966175T3 (en)Pharmaceutical compositions containing cortexolone-17-alpha-propionate
IL200125A0 (en)Pharmaceutical composition
GB0608724D0 (en)Novel Pharmaceutical Compositions
EP2224805A4 (en)Pharmaceutical composition
GB0610322D0 (en)Novel pharmaceutical compositions
EP2224915A4 (en)Pharmaceutical composition
EP2146695A4 (en)Pharmaceutical compositions
EP2224808A4 (en)Pharmaceutical composition
GB0709811D0 (en)Pharmaceutical compositions
GB0707127D0 (en)Pharmaceutical compositions
IL205975A0 (en)Pharmaceutical composition
GB0712454D0 (en)Pharmaceutical compositions
IL205931A0 (en)Pharmaceutical composition
GB2454923B (en)Pharmaceutical compositions
IL201394A0 (en)Niacin - based pharmaceutical compositions
HU0700755D0 (en)Pharmaceutical compositions containing capsaicionid
GB0701364D0 (en)Novel pharmaceutical compositions
GB0701368D0 (en)Novel pharmaceutical compositions
GB0704749D0 (en)Novel pharmaceutical compositions

Legal Events

DateCodeTitleDescription
ATApplications terminated before publication under section 16(1)
[8]ページ先頭
©2009-2025 Movatter.jp